Kura Oncology (KURA): Chief Operating Officer sold, ~$39K

~$39K
Approx. value · 3,668 sh @ $10.75: 143K
Holds after · shares reported

Traded: Sep 29, 2026
Filed: Sep 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Aug 12, 2026Company filing · Form 8-K · ResultsReported its results
Sep 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective as of September 8, 2026, the Board of Directors (the “Board”) of Kura Oncology, Inc. (the “Company”) appointed Jennifer Fulk as the Company’s Chief Financial Officer, principal financial officer (replacing Troy E. Wilson, Ph.D., J.D. solely with respect to such role) and principal accounting officer (replacing Thomas Doyle solely with respect to such role).”
Sep 24, 2026InsiderOfficer sold ~$225K of KURA shares in the open market
Sep 28, 2026Insider · 5 peopleInsiders: 6 sales (~$519K)
Sep 29, 2026 · this disclosureInsiderOfficer sold ~$39K of KURA shares in the open market

What came next

Sep 29, 2026Insider · 2 peopleInsiders: 2 sales (~$475K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Kura Oncology

For Kura Oncology, OQRO holds 10 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KURA page.

Other recent filings by Kathleen Ford, Chief Operating Officer

The full history of Kathleen Ford, Chief Operating Officer is on the profile page.

Other disclosures at Kura Oncology

Everything OQRO holds on this company is on its KURA page.

Kura Oncology (KURA)Chief Operating Officer sold ~$39K